×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Innate Immune Pattern Recognition in 4R-Tauopathies
mechanism
2,206 words
KG: Innate Immune Pattern Recognition in 4R-Tauopathies
2026-04-01
kind:mechanism
section:mechanisms
state:published
Contents
Innate Immune Pattern Recognition in 4R-Tauopathies
⚙
Mechanism Info
Name
Innate Immune Pattern Recognition in 4R-Tauopathies
Summary
Cross-disease comparison of TLR signaling, NLRP3 inflammasome, cGAS-STING pathway, and DAMPs across PSP, CBD, AGD, GGT, and FTDP-17
Knowledge Graph
Related Hypotheses (23)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.53
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Microbial Inflammasome Priming Prevention
Score: 0.58
Senescent Cell Mitochondrial DNA Release
Score: 0.54
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62
Enteric Nervous System Prion-Like Propagation Blockade
Score: 0.44
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60
DAMP-Scavenging Microglial Reset
Score: 0.46
Glymphatic-Mediated Tau Clearance Dysfunction
Score: 0.55
Dual-Circuit Tau Vulnerability Cascade
Score: 0.50
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio
Score: 0.49
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
APOE-TREM2 Interaction Modulation
Score: 0.48
Ocular Immune Privilege Extension
Score: 0.47
LRP1-Dependent Tau Uptake Disruption
Score: 0.44
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43
Gap Junction Hemichannel Modulation for Controlled Mitochond
Score: 0.39
Show 18 more
Related Analyses (30)
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Show 25 more
Related Experiments (15)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90
Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90
RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90
Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90
TLR expression analysis in Parkinson's disease patients
clinical · proposed · Score: 0.85
TLR4 Activation Assay with NETs and Anti-CarP Antibodies
exploratory · proposed · Score: 0.85
Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80
TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80
cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40
Endothelium-specific TBK1 knockdown in atherosclerosis model
validation · proposed · Score: 0.90
TBK1-PAK1IP1-PAK1 signaling pathway analysis
exploratory · proposed · Score: 0.90
LC-MS/Western blot analysis of TBK1 in atherosclerotic arter
exploratory · proposed · Score: 0.80
Show 10 more
See Also (15)
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 5 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 5 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 5 hypotheses
Sex Differences in Neurodegeneration
mechanism · Pages share 5 hypotheses
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 5 hypotheses
Retinal Degeneration Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
Microglial Priming Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
Lipid Metabolism Dysregulation in Neurodegeneration
mechanism · Pages share 5 hypotheses
IL-1 Signaling Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
HMGB1 Signaling in Neurodegeneration
mechanism · Pages share 5 hypotheses
gp130/IL-6 Family Cytokine Signaling in Neurodegenerati
mechanism · Pages share 5 hypotheses
Galectin-3 Mechanism in Neurodegeneration
mechanism · Pages share 5 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 5 hypotheses
Dystrophic Neurites in Neurodegeneration
mechanism · Pages share 5 hypotheses
Down Syndrome Neurodegeneration Pathway
mechanism · Pages share 5 hypotheses
Show 10 more